University of New South Wales, Australia recently announced on the official website to find the source of dilated cardiomyopathy gene appeared breakthroughs, which provides a method for early diagnosis of this serious disease.
Dilated cardiomyopathy is often a cause of unknown primary myocardial disease characterized by left or right ventricle or bilateral ventricular enlargement, and accompanied by ventricular systolic dysfunction, heart failure. The past 10 years, researchers have been hoping to find the source of genes that cause the disease, but the effect of small-scale research is not obvious.
Recently, a large international research team on 5267 patients with dilated cardiomyopathy gene were analyzed and published in mid-January of the relevant research results.
Involved in the study researchers at the University of New South Wales Diane Fatkin said the study found that patients with dilated cardiomyopathy easier than ordinary existence titin mutations. The findings in the diagnosis of dilated cardiomyopathy is a “milestone” type. You can now dilated cardiomyopathy relatives titin mutation testing, and implementation of human mutated general preventive treatment. This family of genetic testing may become routine measures to manage the treatment of dilated cardiomyopathy, which is unprecedented.